Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Altucci

Showing results (41-50 of 358) with videos related to

Pageof 36
Sort By:
Molecular Oncology|October 30, 2012
Trials with 'epigenetic' drugs: an updateAngela Nebbioso, Vincenzo Carafa, Rosaria Benedetti, et al.
Expert Opinion on Therapeutic Patents|May 29, 2009
Histone acetyltransferase inhibitors and preclinical studiesFabio Manzo, Francesco Paolo Tambaro, Antonello Mai, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2022
MicroRNA Expression Profiling Using Agilent One-Color MicroarrayCarmela Dell'Aversana, Giulia Sgueglia, Nunzio Del Gaudio, et al.
Plos Genetics|June 8, 2018
Cancer epigenetics: Moving forwardAngela Nebbioso, Francesco Paolo Tambaro, Carmela Dell'Aversana, et al.
Frontiers in Endocrinology|October 31, 2017
Breast Cancer Vaccines: New InsightsRosaria Benedetti, Carmela Dell'Aversana, Cristina Giorgio, et al.
Cancers|July 18, 2020
The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic OptionsAntonella Di Costanzo, Nunzio Del Gaudio, Lidio Conte, et al.
Archives of Toxicology|August 3, 2014
Epigenetic drugs against cancer: an evolving landscapeAntonella Di Costanzo, Nunzio Del Gaudio, Antimo Migliaccio, et al.
Current Topics in Medicinal Chemistry|November 2, 2011
Epigenetic multiple modulatorsRosana Álvarez, Lucia Altucci, Hinrich Gronemeyer, et al.
Expert Opinion on Therapeutic Targets|June 2, 2015
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemiaAngela Nebbioso, Rosaria Benedetti, Mariarosaria Conte, et al.
Clinical Epigenetics|December 20, 2022
NAA60 (HAT4): the newly discovered bi-functional Golgi member of the acetyltransferase familyFederica Donnarumma, Valeria Tucci, Concetta Ambrosino, et al.
Pageof 36

Showing results (41-50 of 358) with videos related to

Sort By:
Pageof 36
Molecular Oncology|October 30, 2012
Trials with 'epigenetic' drugs: an updateAngela Nebbioso, Vincenzo Carafa, Rosaria Benedetti, et al.
Expert Opinion on Therapeutic Patents|May 29, 2009
Histone acetyltransferase inhibitors and preclinical studiesFabio Manzo, Francesco Paolo Tambaro, Antonello Mai, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2022
MicroRNA Expression Profiling Using Agilent One-Color MicroarrayCarmela Dell'Aversana, Giulia Sgueglia, Nunzio Del Gaudio, et al.
Plos Genetics|June 8, 2018
Cancer epigenetics: Moving forwardAngela Nebbioso, Francesco Paolo Tambaro, Carmela Dell'Aversana, et al.
Frontiers in Endocrinology|October 31, 2017
Breast Cancer Vaccines: New InsightsRosaria Benedetti, Carmela Dell'Aversana, Cristina Giorgio, et al.
Cancers|July 18, 2020
The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic OptionsAntonella Di Costanzo, Nunzio Del Gaudio, Lidio Conte, et al.
Archives of Toxicology|August 3, 2014
Epigenetic drugs against cancer: an evolving landscapeAntonella Di Costanzo, Nunzio Del Gaudio, Antimo Migliaccio, et al.
Current Topics in Medicinal Chemistry|November 2, 2011
Epigenetic multiple modulatorsRosana Álvarez, Lucia Altucci, Hinrich Gronemeyer, et al.
Expert Opinion on Therapeutic Targets|June 2, 2015
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemiaAngela Nebbioso, Rosaria Benedetti, Mariarosaria Conte, et al.
Clinical Epigenetics|December 20, 2022
NAA60 (HAT4): the newly discovered bi-functional Golgi member of the acetyltransferase familyFederica Donnarumma, Valeria Tucci, Concetta Ambrosino, et al.
Pageof 36